Jeff Eliot Margolis

All filings by Jeff Eliot Margolis on record concern RespireRx Pharmaceuticals Inc. Between 14 April 2014 and 30 September 2020, the trades on record add up to 21 filings.

No open-market purchase appears, only 1 sale. The amount is not disclosed for 1 filing. Besides market trades, the filings include 2 share grants.

The latest filing, published on 2 October 2020, reports a transaction in RespireRx Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.